Dr. Green is an Associate Professor and the Director of Translational and Laboratory Research in the Department of Lymphoma & Myeloma at the University of Texas MD Anderson Cancer Center. His laboratory focusses on understanding how changes in gene function lead to lymphoma, and alter the way that lymphoma cells interact with the immune system. To do this, the Dr. Green’s laboratory employ’s cutting edge genomic technologies to analyze human tumors, patient derived xenograft models and transgenic mouse models, with the goal of identifying dependencies that can be therapeutically targeted. Dr. Green received support through an LLS Special Fellow award as a postdoctoral fellow at Stanford University, where he highlighted the importance of mutations in the CREBBP gene in follicular lymphoma. Now, with the support of an LLS Scholar Award, he aims to investigate the mechanisms by which mutations in CREBBP drive lymphoma and how these may inform novel rationally-designed therapeutic approaches.